Cayman Chemical has supplied small molecules, biochemicals, assay kits, analytical standards, antibodies, and proteins to neuroscientists worldwide for over 40 years. We specialize in developing products that support the areas of lipid and endocannabinoid signaling, behavioral neuroscience, pain research, neurodegenerative disorders, and psychedelic therapy and substance use disorders.
Cayman also offers a diverse suite of services that leverages over 170 scientists with expertise in medicinal chemistry, structural biology, bioanalysis, custom assay development, complex multi-step organic synthesis, analytical chemistry, GMP API manufacturing, and more. We offer a personalized, flexible approach that enables our clients to answer research questions from basic biology to drug discovery and development.